Dr. Swaroopa Yerrabothala
Claim this profileDartmouth Hitchcock Medical Center
Studies Leukemia
Studies Myeloid Leukemia
5 reported clinical trials
10 drugs studied
Area of expertise
1Leukemia
IDH positive
FLT3 positive
BCR-ABL1 positive
2Myeloid Leukemia
IDH positive
FLT3 positive
BCR-ABL1 positive
Affiliated Hospitals
Clinical Trials Swaroopa Yerrabothala is currently running
Pembrolizumab + Chemotherapy
for Acute Myeloid Leukemia
This phase II trial studies how well cytarabine and idarubicin or daunorubicin with or without pembrolizumab work in treating patients with newly-diagnosed acute myeloid leukemia. Chemotherapy drugs, such as cytarabine, idarubicin, and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving induction chemotherapy with pembrolizumab may work better than induction chemotherapy alone in treating patients with acute myeloid leukemia.
Recruiting1 award Phase 210 criteria
Asciminib
for Chronic Myeloid Leukemia
This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP- binding site TKI with discontinuation due to treatment failure, warning or intolerance. (2L patient cohort). In addition, newly diagnosed CML-CP patients who may have received up to 4 weeks of prior TKI are included in a separate 1L patient cohort.
Recruiting1 award Phase 21 criteria
More about Swaroopa Yerrabothala
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Swaroopa Yerrabothala has experience with
- Cytarabine
- Pembrolizumab
- Daunorubicin Hydrochloride
- Idarubicin Hydrochloride
- Venetoclax
- Azacitidine
Breakdown of trials Swaroopa Yerrabothala has run
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Swaroopa Yerrabothala specialize in?
Swaroopa Yerrabothala focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved IDH positive patients, or patients who are FLT3 positive.
Is Swaroopa Yerrabothala currently recruiting for clinical trials?
Yes, Swaroopa Yerrabothala is currently recruiting for 2 clinical trials in Lebanon New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Swaroopa Yerrabothala has studied deeply?
Yes, Swaroopa Yerrabothala has studied treatments such as Cytarabine, Pembrolizumab, Daunorubicin Hydrochloride.
What is the best way to schedule an appointment with Swaroopa Yerrabothala?
Apply for one of the trials that Swaroopa Yerrabothala is conducting.
What is the office address of Swaroopa Yerrabothala?
The office of Swaroopa Yerrabothala is located at: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756 United States. This is the address for their practice at the Dartmouth Hitchcock Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.